Syndax Pharmaceuticals Inc (SNDX) Stock Analysis

Syndax Pharmaceuticals Inc (SNDX) is a publicly traded company in the HEALTHCARE sector. It trades at $18.39, carries a market capitalization of $1.67B. This page summarizes the public market data, fundamentals, and frequently asked questions for SNDX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Syndax Pharmaceuticals Inc currently has a Bullish sentiment score of 0.25.

About Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts, focused on developing innovative therapies for the treatment of cancer. The company's robust pipeline includes novel agents designed to address significant unmet medical needs in various malignancies, leveraging both immuno-oncology and epigenetic modulation strategies. Syndax is committed to advancing its clinical programs to improve outcomes for patients facing challenging cancer diag...

GNG Research Analysis

GNG Research scores Syndax Pharmaceuticals Inc (SNDX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SNDX.

Frequently Asked Questions

Does SNDX pay dividends?

Syndax Pharmaceuticals Inc (SNDX) does not currently pay a regular dividend.

What is SNDX's market cap?

Syndax Pharmaceuticals Inc (SNDX) has a market capitalization of $1.67B with a current stock price of $18.39.